showed that the overexpression of miR-495 significantly reduced the drug efflux in MDR OC cell line A2780DX5 and GC cell line SGC7901R by directly targeting ABCB1, thereby enhancing the sensitivity of cancer cells to DOX and paclitaxel (PTX) (153). The gene discussed is ABCB1; the disease is gastric cancer.